Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Organic Chemistry|February 22, 2019
Phospholones from Diacetylenic Ketones: Synthesis, Properties, and ReactivityMartin Obermeier, Anna I ArkhypchukMMW Fortschritte Der Medizin|June 19, 2021
[Comparison of HIV therapy applied in urban and rural areas - results of a retrospective study between Berlin and Greifswald/ Vorpommern]Lisa Wunsch, Michael Jünger, Martin ObermeierJournal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 19, 2022
Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loadsRobert Ehret, Kudor Harb, Stefan Breuer, et al.Current Opinion in HIV and AIDS|July 27, 2012
HIV population genotypic tropism testing and its clinical significanceMartin Obermeier, Jori Symons, Annemarie M J WensingMicrobiology Spectrum|March 10, 2026
Analytical and clinical evaluation of the Alinity m Resp-4-Plex assay in comparison to two singleplex SARS-CoV-2 assays and one multiplex respiratory assayRobert Ehret, Malik Prentice, Birgit Reinhardt, et al.Intervirology|July 19, 2014
Hepatitis B virus drug resistance tools: one sequence, two predictionsMaria Neumann-Fraune, Bastian Beggel, Rolf Kaiser, et al.Journal of Virological Methods|October 25, 2021
Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assaysRobert Ehret, Stefan Breuer, Jens Dhein, et al.Journal of the International AIDS Society|November 15, 2014
Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratoryRobert Ehret, Stefan Neifer, Hauke Walter, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2012
The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assaysJens Verheyen, Maria Neumann-Fraune, Thomas Berg, et al.Journal of the International AIDS Society|November 14, 2014
Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatmentRobert Ehret, Hauke Walter, Patrick Ingiliz, et al.Pageof 5